Full List Of Stories
London close: Benchmark finishes weaker amid surge in unemployment
London’s benchmark index remained below the waterline by the close on Tuesday as data revealed a surge in unemployment claims.
Online Blockchain confirms first 'halving' of Brazio cryptocurrency
Online Blockchain announced on Tuesday that its ‘Brazio’ cryptocurrency had hit another “significant” milestone.
Live Company withdraws guidance as it looks towards zoo reopenings
Independent LEGO-focussed events firm Live Company Group updated the market on Tuesday, noting that countries including Germany, the Czech Republic and Austria had now opened some zoos.
Hydrodec still working on funding deal amid tough market conditions
Industrial oil re-refining company Hydrodec Group updated the market on its ongoing trading on Tuesday, reporting that the current conditions were “unprecedented”, and provided additional challenges to those it had already outlined in February.
Portmeirion partially reopens Stoke ceramics factory
Homewares company Portmeirion Group updated the market on its trading on Tuesday, confirming that it has partially reopened its Stoke-on-Trent ceramic factory as of 6 May.
Aminex clears last major hurdle for Ruvuma farm-out approval
Aminex updated the market on progress towards completion of the Ruvuma farm-out, on Tuesday, reporting that following payment by its subsidiary of the capital gains tax bill, and payment by ARA Petroleum Tanzania of the stamp duty bill, the Tanzania Revenue Authority has issued a tax clearance certificate to the company.
Alpha FX ropes in James Carey as tech director
Foreign exchange risk management and payments company Alpha FX Group announced the appointment of James Carey as its director of technology on Tuesday, with immediate effect.
Induction Healthcare to acquire digital patient platform Zesty
Induction Healthcare has entered into a conditional share purchase agreement to acquire Zesty - a digital healthcare patient engagement platform company - for a consideration of £0. 5m cash and the issue of 12,424,527 new ordinary shares, it announced on Tuesday.
Asia report: Markets rise on positive Covid vaccine developments
Markets in Asia were sparkling green across the board as they closed on Tuesday, as investors cheered positive phase one results for a potential Covid-19 coronavirus vaccine from US firm Moderna Therapeutics overnight.
Itaconix nets $0.2m under US Paycheck Protection Program
Itaconix has received $0. 2m (£0. 16m) in new funding from a loan under the US Small Business Administration's Paycheck Protection Program, it announced on Tuesday.
Diaceutics maintains expectations after first quarter
Diaceutics said it had made a “good start” to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Alumasc's Gatic wins £4m in contracts in last three months
Building products and systems company Alumasc announced on Tuesday that its subsidiary Gatic has been awarded a number of contracts in the Middle and Far East in the last three months, totalling more than £4m.
Renew delivers record first half, dividend still suspended
Engineering services group Renew Holdings delivered “another record trading period” in its half-year report on Tuesday, with “strong” cash generation and trading performance, including a contribution from the acquisition of Carnell Support Services in January, although its interim dividend remained suspended.
Micro Focus reaches upper end of margin expectations in first half
Micro Focus said on Tuesday that it was expecting to report revenue of around $1. 45bn (£1. 19bn) for the first half, making for a decline of around 11% on a constant currency basis.
Imperial Brands slashes dividend, Compass raising £2bn of equity
London open The FTSE 100 is expected to open 42 points higher on Tuesday, having closed up 4. 29% at 6,048. 59 on Monday.
US close: Markets finish higher on vaccine hopes
US stocks finished firmly higher on Monday, as Jerome Powell said he was optimistic of the US economy's ability to bounce back from the Covid-19 pandemic, and amid positive data from Moderna Therapeutics' second phase clinical trial on a vaccine candidate for the coronavirus.